Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Arcus Biosciences Inc (RCUS)  
$15.26 0.30 (1.93%) as of 4:30 Wed 5/8


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 64,920,000
Market Cap: 990.68(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $13.43 - $23.54
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    : 31.4
Insider 3/6 Months : 32
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Arcus Biosciences is a clinical-stage biopharmaceutical company focused on creating cancer therapies. Co.'s products include: Domvanalimab, which is an anti-TIGIT monoclonal antibody designed to promote sustained immune activation and tumor clearance; Etrumadenant, which is a dual A2a/A2b adenosine receptor antagonist, designed to inhibit the adenosine-driven impairment of tumor-infiltrating lymphocytes and myeloid cells; AB680, which is a potent and selective small-molecule CD73 inhibitor designed to provide differential benefits relative to monoclonal antibodies; and Zimberelimab, which is Co.'s anti-PD-1 antibody that Co. in-licensed to enable the development of its combination regimens.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 15,238,095 16,248,095 16,248,095
Total Buy Value $0 $319,999,995 $339,452,595 $339,452,595
Total People Bought 0 1 1 1
Total Buy Transactions 0 1 2 2
Total Shares Sold 110,657 141,439 237,875 329,459
Total Sell Value $2,164,815 $2,731,452 $4,652,676 $7,003,905
Total People Sold 2 4 4 6
Total Sell Transactions 6 10 16 33
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 88
  Page 4 of 4  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Rosen Terry J Chief Executive Officer   •       •      –    2022-06-17 4 S $21.71 $102,034 D/D (4,613) 227,716 -31%     
   Jarrett Jennifer Chief Operating Officer   •       •      –    2022-06-17 4 S $21.71 $146,294 D/D (6,614) 118,619 -31%     
   Jaen Juan C. President   •       •      –    2022-06-16 4 S $20.72 $48,340 D/D (2,333) 212,574 -36%     
   Tang Carolyn C. General Counsel   •       –      –    2022-06-16 4 S $20.72 $29,008 D/D (1,400) 25,431 -36%     
   Rosen Terry J Chief Executive Officer   •       •      –    2022-06-16 4 S $20.72 $87,874 D/D (4,241) 232,329 -36%     
   Jarrett Jennifer Chief Operating Officer   •       •      –    2022-06-16 4 S $20.72 $125,998 D/D (6,081) 125,233 -36%     
   Falberg Kathryn E Director   –       •      –    2022-06-14 4 A $0.00 $0 D/D 4,100 90,604     -
   Machado Clarence Patrick Director   –       •      –    2022-06-14 4 A $0.00 $0 D/D 4,100 10,100     -
   Lacey David L. Director   –       •      –    2022-06-14 4 A $0.00 $0 D/D 4,100 42,452     -
   Perlman Andrew J Director   –       •      –    2022-06-14 4 A $0.00 $0 D/D 4,100 11,125     -
   Kaneko Yasunori Director   –       •      –    2022-06-14 4 A $0.00 $0 D/D 4,100 4,100     -
   Lambert Nicole Director   –       •      –    2022-06-14 4 A $0.00 $0 D/D 4,100 4,100     -
   Ribas Antoni Director   –       •      –    2022-06-14 4 A $0.00 $0 D/D 4,100 15,150     -
  88 Records found
  1  2  3  4    
  Page 4 of 4
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us